Literature DB >> 11869753

Principles of effectiveness trials and their implementation in VA Cooperative Study #430: 'Reducing the efficacy-effectiveness gap in bipolar disorder'.

M S Bauer1, W O Williford, E E Dawson, H S Akiskal, L Altshuler, C Fye, A Gelenberg, H Glick, B Kinosian, M Sajatovic.   

Abstract

Despite the availability of efficacious treatments for bipolar disorder, their effectiveness in general clinical practice is greatly attenuated, resulting in what has been called an 'efficacy-effectiveness gap'. In designing VA Cooperative Studies Program (CSP) Study #430 to address this gap, nine principles for conducting an effectiveness (in contrast to an efficacy) study were identified. These principles are presented and discussed, with specific aspects of CSP #430 serving as illustrations of how they can be implemented in an actual study. CSP #430 hypothesizes that an integrated, clinic-based treatment delivery system that emphasizes (1) algorithm-driven somatotherapy, (2) standardized patient education, and (3) easy access to a single primary mental health care provider to maximize continuity-of-care, will address the efficacy-effectiveness gap and improve disease, functional, and economic outcome. It is an 11-site, randomized controlled clinical trial of this multi-modal, clinic-based intervention versus usual VA care running from 1997 to 2003. The trial has enrolled 191 subjects in each arm, using minimal exclusion criteria to maximize the external validity of the study. Subjects are followed for 3 years. The intervention is highly specified in a series of operations manuals for each of the three components. Several continuous quality improvement (CQI) interventions, process measures, and statistical techniques deal with drift of care in both the intervention and usual care arms to ensure the internal validity of the study. CSP #430 is designed to have impact well beyond the VA, since it evaluates a basic health care operational principle: that augmenting ambulatory access for major mental illness will improve outcome and reduce overall treatment costs. If results are positive, this study will provide a reason to reconsider the prevailing trend toward limitation of ambulatory services that is characteristic of many managed care systems today.

Entities:  

Mesh:

Year:  2001        PMID: 11869753     DOI: 10.1016/s0165-0327(01)00440-2

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  25 in total

1.  A randomized, double-blind, placebo-controlled, trial of lamotrigine therapy in bipolar disorder, depressed or mixed phase and cocaine dependence.

Authors:  E Sherwood Brown; Prabha Sunderajan; Lisa T Hu; Sharon M Sowell; Thomas J Carmody
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

2.  Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact.

Authors:  Geoffrey M Curran; Mark Bauer; Brian Mittman; Jeffrey M Pyne; Cheryl Stetler
Journal:  Med Care       Date:  2012-03       Impact factor: 2.983

3.  Psychotherapy for Bipolar Disorder in Adults: A Review of the Evidence.

Authors:  Holly A Swartz; Joshua Swanson
Journal:  Focus (Am Psychiatr Publ)       Date:  2014

4.  Nicotine replacement therapy for smoking cessation in the "real world".

Authors:  Saul Shiffman
Journal:  Thorax       Date:  2007-11       Impact factor: 9.139

5.  Effectiveness of Using Incentives to Improve Parolee Admission and Attendance in Community Addiction Treatment.

Authors:  Michael L Prendergast; Elizabeth A Hall; Jason Grossman; Robert Veliz; Liliana Gregorio; Umme S Warda; Kory Van Unen; Chloe Knight
Journal:  Crim Justice Behav       Date:  2015-07-10

6.  Memory performance predicts recurrence of mania in bipolar disorder following psychotherapy: A preliminary study.

Authors:  Isabelle E Bauer; Martin Hautzinger; Thomas D Meyer
Journal:  J Psychiatr Res       Date:  2016-10-11       Impact factor: 4.791

Review 7.  Over-the-counter nicotine replacement therapy: can its impact on smoking cessation be enhanced?

Authors:  Nancy Amodei; R J Lamb
Journal:  Psychol Addict Behav       Date:  2008-12

8.  Are adults with bipolar disorder active? Objectively measured physical activity and sedentary behavior using accelerometry.

Authors:  Carol A Janney; Andrea Fagiolini; Holly A Swartz; John M Jakicic; Robert G Holleman; Caroline R Richardson
Journal:  J Affect Disord       Date:  2013-09-18       Impact factor: 4.839

9.  Comparative efficacy versus effectiveness of initial antiretroviral therapy in clinical trials versus routine care.

Authors:  Justin S Routman; James H Willig; Andrew O Westfall; Sarah R Abroms; Mohit Varshney; Sunil Adusumilli; Jeroan J Allison; Karen G Savage; Michael S Saag; Michael J Mugavero
Journal:  Clin Infect Dis       Date:  2010-02-15       Impact factor: 9.079

10.  A randomized, double-blind, placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase, and alcohol dependence.

Authors:  E Sherwood Brown; Domingo Davila; Alyson Nakamura; Thomas J Carmody; A John Rush; Alexander Lo; Traci Holmes; Bryon Adinoff; Raul Caetano; Alan C Swann; Prabha Sunderajan; Mary E Bret
Journal:  Alcohol Clin Exp Res       Date:  2014-06-27       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.